The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Uromitexan Tablets 600mg

Baxter Holding B.V.PA2299/024/003

Main Information

Trade NameUromitexan Tablets 600mg
Active SubstancesMesna
Dosage FormFilm-coated tablet
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/024/003

Group Information

ATC CodeV03AF Detoxifying agents for antineoplastic treatment
V03AF01 mesna


License statusAuthorised
Licence Issued30/04/1996
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back